The goal of mortality prediction task is to predict the future death risk of patients according to their previous Electronic Healthcare Records (EHR). The main challenge of mortality prediction is how to design an accurate and robust predictive model with sequential, multivariate, sparse and irregular EHR data. In addition, the performance of model may be affected by lack of sufficient information of some patients with rare diseases in EHRs. To address these challenges, we propose a model to fuse Sequential visits and Medical Ontology to predict patients' death risk. SeMO not only learns reasonable embeddings for medical concepts from sequential and irregular visits, but also exploits medical ontology to improve the prediction performance. With integration of multivariate features, SeMO learns robust representations of medical codes, mitigating data insufficiency and insightful sequential dependencies among patient's visits. Experimental results on real world datasets prove that the proposed SeMO improves the prediction performance compared with the baseline approaches. Our model achieves an precision of up to 0.975. Compared with RNN, the precision has been improved up to 2.204%.

Download full-text PDF

Source
http://dx.doi.org/10.1016/j.jbi.2022.104012DOI Listing

Publication Analysis

Top Keywords

medical ontology
12
mortality prediction
12
sequential visits
8
visits medical
8
death risk
8
semo learns
8
prediction performance
8
medical
5
prediction
5
fusion sequential
4

Similar Publications

Chemotherapy is a potent tool against cancer, but drug resistance remains a major obstacle. To combat this, understanding the molecular mechanisms behind resistance in cancer cells and the protein expression changes driving these mechanisms is crucial. Targeting the Ubiquitin-Proteasome System (UPS) has proven effective in treating multiple myeloma and shows promise for solid tumours.

View Article and Find Full Text PDF

The Homo sapiens Chromosomal Location Ontology (HSCLO) is designed to facilitate the integration of human genomic features into biomedical knowledge graphs from releases GRCh37 and GRCh38 at multiple resolutions. HSCLO comprises two distinct versions, HSCLO37 and HSCLO38, each tailored to its respective human genome release. This ontology supports the efficient integration and analysis of human genomic data across scales ranging from entire chromosomes to individual base pairs, thereby enhancing data retrieval and interoperability within large-scale biomedical datasets.

View Article and Find Full Text PDF

is a species closely linked to human health. This study investigated the acaricidal efficacy of methanol extracts from 18 traditional Chinese medicinal plants against . The extract from DC.

View Article and Find Full Text PDF

Clear cell renal cell carcinoma (ccRCC) is a highly malignant tumor characterized by a significant propensity for recurrence and metastasis. DNA methylation has emerged as a critical epigenetic mechanism with substantial utility in cancer diagnosis. In this study, multi-omics data were utilized to investigate the target genes regulated by the transcription factor MYC-associated zinc finger protein (MAZ) in ccRCC, leading to the identification of thymidine phosphorylase (TYMP) as a gene with notably elevated expression in ccRCC.

View Article and Find Full Text PDF

: Fructus (AOF) is a medicinal and edible resource that holds potential to ameliorate hyperuricemia (HUA), yet its mechanism of action warrants further investigation. : We performed network pharmacology, molecular docking, molecular dynamics simulation, and in vitro experiments to investigate the potential action and mechanism of AOF against HUA. : The results indicate that 48 potential anti-HUA targets for 4 components derived from AOF were excavated and predicted through public databases.

View Article and Find Full Text PDF

Want AI Summaries of new PubMed Abstracts delivered to your In-box?

Enter search terms and have AI summaries delivered each week - change queries or unsubscribe any time!